Stock Research: Sanofi India

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Sanofi India

BSE:500674 INE058A01010
40
  • Value
    54
  • Growth
    14
  • Safety
    Safety
    72
  • Combined
    39
  • Sentiment
    46
  • 360° View
    360° View
    40
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Sanofi India Limited manufactures and trades drugs and pharmaceuticals. The company focuses on therapeutic areas including diabetes (Lantus, Toustar), epilepsy (Frisium), cardiology (Cardace), allergy (Allegra, Avil), and pain care (Combiflam). It operates mainly in India, with a manufacturing facility in Goa and around 12 contract manufacturing organizations. In the last fiscal year, the company had a market cap of $1577 million, profits of $119 million, revenue of $235 million, and 991 employees.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
54 35 43 55
Growth
14 11 31 7
Safety
Safety
72 83 75 97
Sentiment
46 83 45 94
360° View
360° View
40 59 43 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
76 97 87 97
Opinions Change
50 50 50 50
Pro Holdings
n/a 50 25 92
Market Pulse
22 84 29 27
Sentiment
46 83 45 94
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
54 35 43 55
Growth
14 11 31 7
Safety Safety
72 83 75 97
Combined
39 23 47 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
63 42 50 50
Price vs. Earnings (P/E)
45 36 29 39
Price vs. Book (P/B)
18 10 14 43
Dividend Yield
82 67 76 82
Value
54 35 43 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
31 23 32 8
Profit Growth
14 12 59 32
Capital Growth
50 19 17 9
Stock Returns
17 47 83 25
Growth
14 11 31 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
80 84 82 92
Refinancing
31 32 32 48
Liquidity
88 90 88 92
Safety Safety
72 83 75 97

Similar Stocks

Discover high‑ranked alternatives to Sanofi India and broaden your portfolio horizons.

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Fleury

BOVESPA:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Maruti Suzuki

NSEI:MARUTI
Country: India
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Bosch

BSE:500530
Country: India
Industry: Auto Parts & Equipment
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: